Check out Pro
Top Companies
Recent Trades
Cluster Buys
Sectors
Blog
Join the Insiderviz Pro waitlist
Nautilus Biotechnology, Inc. (NAUT)
All trades on this company by insiders. Hover over bubbles for specific trade details. Drag along the graph for custom price change. Green - Buy, Red - Sell, Orange - Congress Member.
Healthcare
Biotechnology
DATE
INSIDER
COMPANY
OWNED SHARES
SHARES TRADED
PRICE
NET TOTAL
BUY
26 Sep 2022
Sankar Subramanian
Senior VP, Product Development, Officer
Nautilus Biotechnology, Inc.
(NAUT)
91,250
+19%
15,000
$2.03
$30,399.00
BUY
23 Sep 2022
Weld Gwen E
Chief People Officer, Officer
Nautilus Biotechnology, Inc.
(NAUT)
30,000
+100%
30,000
$2.03
$60,765.00
BUY
15 Sep 2022
Sankar Subramanian
Senior VP, Product Development, Officer
Nautilus Biotechnology, Inc.
(NAUT)
75,000
+100%
75,000
$2.18
$163,198.00
BUY
19 Aug 2022
Mowry Anna
CFO and Treasurer, Officer
Nautilus Biotechnology, Inc.
(NAUT)
56,750
+44%
17,500
$2.30
$40,218.50
BUY
12 Aug 2022
Murphy Matthew B.
General Counsel, Officer
Nautilus Biotechnology, Inc.
(NAUT)
54,140
+22%
10,000
$2.84
$28,432.50
BUY
5 Aug 2022
Patel Sujal M
CEO, President, and Secretary, Director, Officer, 10% Owner
Nautilus Biotechnology, Inc.
(NAUT)
10,014,488
+0%
50,000
$2.92
$146,090.10
BUY
27 Jun 2022
Mowry Anna
CFO and Treasurer, Officer
Nautilus Biotechnology, Inc.
(NAUT)
39,250
+16%
5,500
$2.75
$15,124.45
BUY
9 May 2022
Patel Sujal M
CEO, President, and Secretary, Director, Officer, 10% Owner
Nautilus Biotechnology, Inc.
(NAUT)
9,964,488
+0%
50,000
$3.96
$198,000.00
BUY
3 Mar 2022
Patel Sujal M
CEO, President, and Secretary, Director, Officer, 10% Owner
Nautilus Biotechnology, Inc.
(NAUT)
9,914,388
+0%
50,000
$3.60
$179,890.00
BUY
8 Dec 2021
PERCEPTIVE ADVISORS LLC
Director
Nautilus Biotechnology, Inc.
(NAUT)
9,111,151
+2%
200,000
$5.36
$1,072,000.00
BUY
30 Nov 2021
Patel Sujal M
CEO, President, and Secretary, Director, Officer, 10% Owner
Nautilus Biotechnology, Inc.
(NAUT)
9,864,388
+2%
250,000
$4.72
$1,181,176.00
BUY
30 Nov 2021
Posard Matthew L.
Director
Nautilus Biotechnology, Inc.
(NAUT)
30,000
+250%
50,000
$4.51
$225,505.00
BUY
24 Nov 2021
Mowry Anna
CFO and Treasurer, Officer
Nautilus Biotechnology, Inc.
(NAUT)
32,500
+85%
15,000
$4.58
$68,632.50
BUY
15 Nov 2021
McIlwain Matthew S
Director
Nautilus Biotechnology, Inc.
(NAUT)
459,075
+27%
100,000
$5.30
$529,890.00
BUY
24 Aug 2021
McIlwain Matthew S
Director
Nautilus Biotechnology, Inc.
(NAUT)
359,075
+11%
36,970
$7.71
$285,040.80
BUY
13 Aug 2021
Murphy Matthew B.
General Counsel, Officer
Nautilus Biotechnology, Inc.
(NAUT)
34,140
+17%
5,000
$7.56
$37,806.50
BUY
12 Aug 2021
Mowry Anna
CFO and Treasurer, Officer
Nautilus Biotechnology, Inc.
(NAUT)
17,500
+100%
17,500
$7.71
$134,925.00
BUY
3 Jun 2021
PERCEPTIVE ADVISORS LLC
Director
ARYA Sciences Acquisition Corp III
(ARYA)
489,975
+206%
330,050
$10.05
$3,317,002.50
BUY
24 May 2021
PERCEPTIVE ADVISORS LLC
Former Director
Nautilus Biotechnology, Inc.
(NAUT)
5,997,038
+1123%
5,507,063
$10.00
$55,070,984.00
BUY
20 May 2021
PERCEPTIVE ADVISORS LLC
Director
ARYA Sciences Acquisition Corp III
(ARYA)
159,925
+100%
159,925
$10.05
$1,607,246.20
Home